2024-11-19 22:35:45
Akeso's Cadonilimab (PD-1/CTLA-4), the First Dual Immune Checkpoint Inhibitor to Treat Cancer, Approved for Marketing in China
Corporate/ 2023-07-24
Akeso's Cadonilimab (PD-1/CTLA-4), ...

Globally first dual immune checkpoint inhibitor bi-specific antibody approved for marketing China\'s first immunotherapy bi-specific antibod...

Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution
Corporate/ 2023-07-24
Seegene to pave way for PCR testing at l...

SEOUL,South Korea,June 29,2022-- Seegene Inc.(KQ096530),South Korea\'s leading molecular diagnostics (MDx) company,has obtained EU approval ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release